The Association between Serum Lipoxin A4 Level and Lupus Nephritis

SERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Serum levels of soluble CD95 in patients with systemic lupus erythematosus

Serum and Circulatory Omentin mRNA Gene Expression as Predictive Markers of Systemic Lupus Erythematosus Disease Activity and Lupus Nephritis

Serum Levels of Soluble Fractalkine in Patients with Systemic Lupus Erythematosus

Assessment of Serum Level of CXCL9 and CXCL10 in Cutaneous versus Systemic Lupus Erythematosus

Serum level of Matrix metalloproteinase-9 in patients with systemic lupus erythematosus.

Anti-Nucleosome Antibody as a Marker of Systemic Lupus Erythematosus Activity

Evaluation of Serum Complement C3 and C4 Levels as biomarkers for Systemic Lupus Erythromatosus

Serum Midkine Levels in Systemic Lupus Erythematosus